Xolair 150mg Injection Solution (Omalizumab)

Xolair 150mg injection contains omalizumab  which is now available in Pakistan at Jasmeds. The price range of the Xolair 20mg injection is Rs.35,000/- to Rs.65,000/-.

Product Description

Brand: Xolair
Packet Size: 1’s injection
Active ingredient: omalizumab
Manufacturer: Novartis
Treatment: Allergic asthma

 50,000

Description

How Xolair Works In The Body

Xolair works by binding to free IgE in the bloodstream, effectively preventing IgE from attaching to its receptor, FcεRI, located on mast cells and basophils. This binding reduces the activation of these cells and limits the release of inflammatory mediators, such as histamines and cytokines, which are responsible for causing allergic symptoms like swelling, itching, and breathing difficulties.

By lowering serum-free IgE levels by up to 95%, Xolair helps reduce the intensity and frequency of allergic reactions. The long-term reduction in IgE levels also decreases the expression of FcεRI receptors on basophils, which contributes to the prolonged suppression of allergic responses. The price of Xolair in Pakistan is quite reasonable, so everyone can afford it.

Order Xolair Today

Xolair is administered as a subcutaneous injection every 2 to 4 weeks, depending on your condition and doctor’s advice.

Consult your healthcare provider to determine if Xolair is the right treatment for your allergic condition and experience relief from allergic asthma and chronic urticaria.

Check the price of Xolair injection and order online delivery from our pharmacy.

We are Pakistan’s leading online pharmacy, offering a wide selection of medicines to meet your healthcare needs.

Additional Details

Uses of the Xolair 150mg Injection 

Xolair 150 mg Injection (omalizumab) is used for several allergic conditions. Here are its primary uses:

Moderate to Severe Persistent Asthma: Xolair is indicated for adults and children aged 6 years and older with moderate to severe persistent asthma that is inadequately controlled with inhaled corticosteroids and who have a positive skin test or in vitro reactivity to perennial aeroallergens.

Chronic Spontaneous Urticaria (CSU): It is used in adults and adolescents aged 12 years and older who remain symptomatic despite treatment with antihistamines.

IgE-Mediated Food Allergies: Xolair is indicated for reducing the risk of severe allergic reactions (anaphylaxis) in individuals aged 1 year and older who have IgE-mediated food allergies. It should be used alongside strict avoidance of the allergen.

Chronic Rhinosinusitis with Nasal Polyps: For adults aged 18 years and older, Xolair serves as add-on therapy for chronic rhinosinusitis with nasal polyps when nasal corticosteroids have not been effective.

Warnings and Precautions of Xolair 150mg Injection

Xolair 150 mg Injection (omalizumab) has several important warnings and precautions that users should be aware of:

Anaphylaxis Risk: There is a significant risk of anaphylaxis, which can manifest as bronchospasm, hypotension, urticaria, and/or angioedema. Anaphylaxis can occur after the first dose or even after prolonged treatment. Patients should be monitored closely in a healthcare setting for a period following administration, and healthcare providers should be prepared to manage severe allergic reactions.

Severe Allergic Reactions: Patients with a known hypersensitivity to omalizumab or any of its components should not use Xolair. It is crucial to inform patients about the signs of severe allergic reactions and instruct them to seek immediate medical help if symptoms occur.

Cancer Risk: There have been reports of malignancies in patients receiving Xolair. Patients should be informed about this potential risk, particularly regarding certain types of cancers.

Infection Risks: Xolair may increase the risk of infections, particularly parasitic infections in individuals living in or traveling to endemic areas. Patients should be aware of symptoms indicating infection and report them promptly.

Use in Specific Populations: Caution is advised when prescribing Xolair to patients with a history of heart attack, stroke, or those receiving allergy shots. Its safety has not been established in children under 6 years or adolescents under 18 for certain indications.

Possible Side Effects of Xolair 150mg Injection

Xolair 150 mg Injection (omalizumab) may cause a variety of side effects, ranging from common to serious. Here’s a concise overview:

Common Side Effects:

Injection Site Reactions: Pain, redness, swelling, or irritation at the injection site.

Headache: Frequent occurrence post-injection.

Dizziness: May affect balance and coordination.

Joint Pain: Discomfort in arms or legs.

Fever: Commonly reported, especially in children.

Nausea and Vomiting: Gastrointestinal disturbances.

Upper Respiratory Infections: Symptoms like sore throat, nasal congestion, or sinusitis.

Fatigue: General tiredness or weakness.

Serious Side Effects

Severe Allergic Reactions: Symptoms include hives, difficulty breathing, swelling of the face or throat, and anaphylaxis. This can occur even after prolonged use.

Cancer Risk: There have been rare reports of malignancies associated with Xolair use; the relationship is not clearly established.

Parasitic Infections: Symptoms may include abdominal pain and diarrhea.

Cardiovascular Issues: Possible heart attack, stroke, or blood clots; symptoms include chest pain, weakness on one side of the body, or sudden vision changes.

FAQ's

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Xolair 150mg Injection Solution (Omalizumab)”

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.